BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Pharm Country

  Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need

  Immunic, Inc. announced that its Celiac Disease R&D Webcast will take place today, February 9, 2023 from 11:00 am to 1:00 pm ET.

  February 9, 2023

   · 

  7 min read
• Genetown

  Voyager Therapeutics to Participate in Upcoming Investor Conferences - February 9, 2023

  Voyager Therapeutics, Inc. today announced that management will participate in the following investor conferences.

  February 9, 2023

   · 

  1 min read
• Business

  Entrada Therapeutics Closes Agreement with Vertex to Discover and Develop Endosomal Escape Vehicle-Therapeutics for Myotonic Dystrophy Type 1 (DM1)

  Entrada Therapeutics, Inc. today announced the expiration of the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 and closing of the Company’s previously announced strategic collaboration and license agreement with Vertex.

  February 9, 2023

   · 

  5 min read
• Compugen to Present at the SVB Securities Global Biopharma Conference

  Compugen Ltd. today announced that management will present at the SVB Securities Global Biopharma Conference (virtual), on Thursday, February 16, 2023 at 9:20 AM ET.

  February 9, 2023

   · 

  1 min read
• Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

  Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 14-16, 2023 in Snowbird, Utah.

  February 9, 2023

   · 

  1 min read
• Genetown

  Aldeyra Therapeutics to Participate in Fireside Chat at the SVB Securities Global Biopharma Conference

  Aldeyra Therapeutics, Inc. today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the SVB Securities Global Biopharma Conference.

  February 9, 2023

   · 

  1 min read
• Deals

  Ensoma Announces Closing of Twelve Bio Acquisition

  Ensoma today announced the closing of its previously announced acquisition of Twelve Bio ApS.

  February 9, 2023

   · 

  1 min read
• Myriad Genetics to Participate in Upcoming Healthcare Conferences

  Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced management will participate at the upcoming healthcare conferences.

  February 9, 2023

   · 

  1 min read
• Business

  Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 1, 2023

  Organogenesis Holdings Inc. today announced that fourth quarter and fiscal year 2022 financial results will be reported after the market closes on Wednesday, March 1st.

  February 9, 2023

   · 

  1 min read
• Biotech Bay

  Kite’s Tecartus® CAR T-Cell Therapy Demonstrates Overall Survival Benefit in Three-Year Follow-up of Pivotal ZUMA-3 Trial in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

  Kite’s Tecartus ® CAR T-Cell Therapy Demonstrates Overall Survival Benefit in Three-Year Follow-up of Pivotal ZUMA-3 Trial in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia.

  February 9, 2023

   · 

  15 min read